ghk-cu dosage subcutaneous topical injection Thermodynamically stable ionic liquid microemulsions pioneer pathways for delivery and peptide application GHK-Cu Dosage: Clinical Guidance for – ghk-cu dosage for subcutaneous injection

Expecting immediate results Quitting after 2 weeks because the scale hasn't moved is premature

It can improve life quality for those with neuropathy

Carneiro JRI1 (1) Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brasil

Czechia 99.0 % purity confirmed by COA Assay content verified at 1106 mg Endotoxin level below 0.001 EU/mg No detectable heavy metals or microbial contamination High-purity NAD+ compound for controlled laboratory research For research use only not for human or veterinary use For laboratory research only

Loren Pickart and colleagues isolated a short peptide from human plasma that extended the lifespan of cultured liver cells. They identified its sequenceglycyl-histidyl-lysine (GHK)and discovered that when bound to copper ions, it formed GHK-Cu, a complex with strong biological activity in cell growth and tissue repair